Parabilis Medicines,
PBLSBiotechnology · NASDAQ · IPO June 10, 2026
01
Company Overview
Parabilis Medicines, is filing to list on NASDAQ Global Select. Public information at this stage is limited to the IPO calendar entry; deeper detail typically becomes available closer to pricing via the company's S-1 / prospectus.
Parabilis Medicines, is going public on NASDAQ Global Select on 2026-06-10. Offering 33,500,000 shares.
Recent headlines
- Parabilis sets a record with a $670M biotech IPO | BioPharma Divebiopharmadive.com
Parabilis boosted the size of its offering and ultimately sold 33.5 million shares at $20 apiece, eclipsing the amounts secured by Moderna in ...
- Parabilis Medicines Makes Wall Street History with $770.5M IPOgenengnews.com
Parabilis is the 15th and latest biotech or pharmaceutical company to carry out an IPO this year, raising a combined $12.11 billion in proceeds, ...
- How to Play PBLS Stock After the Parabilis IPO - Yahoo Financefinance.yahoo.com
Parabilis stock soared on its Nasdaq debut, but a deeper dive suggests PBLS shares could extend gains further through the remainder of 2026.
- The IPO Buzz: Parabilis Medicines (PBLS) Prices Upsized IPO at $20iposcoop.com
Parabilis Medicines (PBLS) stock jumped in its NASDAQ debut today – Wednesday, June 10, 2026 – opening at $33.35 – up $13.35 from its IPO ...
- Parabilis Medicines Inc Stock Price Today | NASDAQ: PBLS Liveinvesting.com
Parabilis Medicines closes $770.5 million IPO and concurrent private placement. Parabilis Medicines Inc. (PBLS) completed its initial public offering on June ...
02
AI Analysis
Possible growth narrative
Sits adjacent to Biotech & Healthcare — themes that are currently drawing meaningful capital and attention.
Risks
Newly public companies typically face limited operating history disclosure, lock-up expirations, and broader market sentiment swings around IPOs.
Volatility
Expect elevated price volatility in the first weeks of trading as supply and demand find balance.
Market attention
Recently listed — monitoring early trading activity and analyst initiations.
Educational summary only. Not investment advice.
03
Related Themes
04
IPO Information
- IPO date
- June 10, 2026
- Exchange
- NASDAQ
- Status
- Recently Listed
- Industry
- Biotechnology
- Valuation
- $3.28B mkt cap
- Headquarters
- US
- Attention score
- 71 / 100
- Ticker
- PBLS